James E. Cary Cancer Center to implement RayStation treatment planning system

NewsGuard 100/100 Score

RaySearch Laboratories AB (STO:RAYB) has received an order for its RayStation® treatment planning system from the James E. Cary Cancer Center located in Hannibal, Missouri.

Hannibal Regional Hospital provides comprehensive radiation therapy services at the James E. Cary Cancer Center to patients throughout northeast Missouri, west-central Illinois and southeast Iowa. Since 2003, the patient care team has been bringing the most current treatments available to patients in the tri-state area while providing the highest level of care and compassion.

The James E. Cary Cancer Center will use RayStation® as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT. The order also includes advanced tools enabling a more efficient treatment planning process, such as Multi-Criteria optimization. This highly intuitive tool lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming treatment planning optimization process.

"RayStation provides the James E. Cary Cancer Center with a complete and comprehensive treatment planning solution for our current needs with the most robust set of planning tools to allow future growth. As the only American College of Radiology accredited center within 100 miles, Raystation will allow us to continue to serve the region's cancer patients at the highest level", says Joseph Bean, M.D., Radiation Oncologist at James E. Cary Cancer Center.

James E. Cary will begin the implementation in March with plans of being clinical in Early April.

"In the beginning of the year we released RayStation® 2.5, the first complete version of RayStation®, and the system has been well received in the market. We note a growing interest for RayStation®, so this order will be followed by many more. We are proud to have The James E. Cary Cancer center has our first customer in the Mid-West and we will work closely together with their team to ensure a smooth clinical implementation", says Johan Löf, CEO of RaySearch.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy